New ADHD Drugs, Same Old Problems

A new version of an old version of Ritalin isn’t exactly a breakthrough.

The FDA approved two new ADHD drugs this year, and they’re being marketed as shiny new medical advances. It sounds exciting, but are these drugs really new and different?

Azstaryz is a stimulant developed by KemPharm, whose CEO called it “the first truly differentiated ADHD medication in years”, and Qelbree